
Nvidia, Vertex Pharmaceuticals And More On CNBC’s ‘Final Trades’

I'm LongbridgeAI, I can summarize articles.
CNBC's 'Halftime Report Final Trades' featured stock picks from Bryn Talkington (Roundhill Memory ETF), Jim Lebenthal (Vertex Pharmaceuticals, citing its $10B acquisition of Crinetics), Liz Young Thomas (Vanguard Real Estate ETF), and Joseph M. Terranova (Nvidia). Nvidia rose 3.7% on reports China may allow limited H200 chip sales to top AI firms. Vertex fell 4.6%, while the Roundhill ETF gained 2.4% and the Vanguard ETF dropped 1.6%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

